Geode Capital Management’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Geode Capital Management’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-114,267	Closed	-$2.79M	–	4120
2017 Q4	$2.79M	Buy	114,267 +1,739	+2%	+$33.4K	﹤0.01%	2569
2017 Q3	$2.08M	Buy	112,528 +9,662	+9%	+$167K	﹤0.01%	2723
2017 Q2	$1.7M	Buy	102,866 +5,449	+6%	+$75.8K	﹤0.01%	2823
2017 Q1	$1.34M	Buy	97,417 +45,310	+87%	+$728K	﹤0.01%	2871
2016 Q4	$988K	Buy	52,107 +3,499	+7%	+$67.1K	﹤0.01%	2999
2016 Q3	$1.08M	Buy	48,608 +933	+2%	+$17.5K	﹤0.01%	2904
2016 Q2	$871K	Buy	47,675 +6,027	+14%	+$104K	﹤0.01%	2973
2016 Q1	$757K	Buy	41,648 +3,160	+8%	+$51.1K	﹤0.01%	3026
2015 Q4	$648K	Buy	38,488 +1,846	+5%	+$31.4K	﹤0.01%	3142
2015 Q3	$660K	Buy	36,642 +1,503	+4%	+$33.5K	﹤0.01%	3091
2015 Q2	$909K	Buy	+35,139	New	+$888K	﹤0.01%	2953

Geode Capital Management's ENTL Position: Q1 2018 in Review

Geode Capital Management sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 114,267 shares — an estimated $2.79M sold.

Geode Capital Management first reported a position in ENTL in Q2 2015 and held it in 11 quarters. The position peaked at $2.79M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Geode Capital Management reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Geode Capital Management sold 114,267 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $2.79M.
Geode Capital Management first reported a position in Entellus Medical, Inc. Common Stock in Q2 2015 and held it in 11 quarters.
Geode Capital Management's Entellus Medical, Inc. Common Stock position peaked at $2.79M in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Geode Capital Management's 13F filing for Q1 2018, filed 15 May 2018.